CW Life Sciences Consulting: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CW Life Sciences Consulting
Largest movements
- Cash +€205,140
up €205,140 (+607%), from €33,812 to €238,952
mainly Net result for the year (+€133,647) and Tax, wage and social debts (+€55,383)
- Receivables within one year -€41,698
down €41,698 (-78.8%), from €52,893 to €11,195
of which Trade receivables: -€42,727
- Tangible fixed assets +€23,924
new in 2025: €23,924
- Reserves +€133,647
up €133,647 (+272%), from €49,088 to €182,735
- Tax, wage and social debts +€55,383
up €55,383 (+246%), from €22,517 to €77,901
of which Taxes: +€53,083
- Trade debts +€8,379
new in 2025: €8,379
- Other debts -€7,538
down €7,538 (-88.5%), from €8,520 to €982
- Gross operating margin +€119,344
up €119,344 (+192%), from €62,014 to €181,358
- Taxes +€27,118
up €27,118 (+212%), from €12,776 to €39,894
- Financial charges +€5,922
up €5,922 (+9,288%), from €64 to €5,986
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €86,705 | €275,759 | +€189,054 | +218% |
| Fixed assets | 21/28 | - | €23,924 | +€23,924 | |
| Tangible fixed assets | 22/27 | - | €23,924 | +€23,924 | |
| Plant, machinery and equipment | 23 | - | €23,924 | +€23,924 | |
| Current assets | 29/58 | €86,705 | €251,835 | +€165,130 | +190% |
| Amounts receivable within one year | 40/41 | €52,893 | €11,195 | -€41,698 | -78.8% |
| Trade receivables | 40 | €52,891 | €10,164 | -€42,727 | -80.8% |
| Other amounts receivable | 41 | €2 | €1,031 | +€1,029 | +48,991% |
| Cash at bank and in hand | 54/58 | €33,812 | €238,952 | +€205,140 | +607% |
| Deferred charges and accrued income | 490/1 | - | €1,688 | +€1,688 | |
| Total equity and liabilities | 10/49 | €86,705 | €275,759 | +€189,054 | +218% |
| Equity | 10/15 | €54,088 | €187,735 | +€133,647 | +247% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €49,088 | €182,735 | +€133,647 | +272% |
| Distributable reserves | 133 | €49,088 | €182,735 | +€133,647 | +272% |
| Amounts payable | 17/49 | €32,617 | €88,024 | +€55,406 | +170% |
| Amounts payable within one year | 42/48 | €32,617 | €88,024 | +€55,406 | +170% |
| Current portion of amounts payable after more than one year | 42 | €1,580 | €0 | -€1,580 | -100% |
| Financial debts | 43 | - | €762 | +€762 | |
| Credit institutions | 430/8 | - | €762 | +€762 | |
| Trade debts | 44 | - | €8,379 | +€8,379 | |
| Suppliers | 440/4 | - | €8,379 | +€8,379 | |
| Taxes, remuneration and social security | 45 | €22,517 | €77,901 | +€55,383 | +246% |
| Taxes | 450/3 | €22,517 | €75,601 | +€53,083 | +236% |
| Remuneration and social security | 454/9 | - | €2,300 | +€2,300 | |
| Other amounts payable | 47/48 | €8,520 | €982 | -€7,538 | -88.5% |
| Remuneration, social security and pensions | 62 | €87 | €570 | +€483 | +557% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €386 | +€386 | |
| Other operating charges | 640/8 | - | €899 | +€899 | |
| Gross operating margin | 9900 | €62,014 | €181,358 | +€119,344 | +192% |
| Operating profit (loss) | 9901 | €61,928 | €179,503 | +€117,575 | +190% |
| Financial income | 75/76B | - | €24 | +€24 | |
| Recurring financial income | 75 | - | €24 | +€24 | |
| Financial charges | 65/66B | €64 | €5,986 | +€5,922 | +9,288% |
| Recurring financial charges | 65 | €64 | €5,986 | +€5,922 | +9,288% |
| Profit (loss) for the period before taxes | 9903 | €61,864 | €173,541 | +€111,677 | +181% |
| Income taxes | 67/77 | €12,776 | €39,894 | +€27,118 | +212% |
| Profit (loss) for the period | 9904 | €49,088 | €133,647 | +€84,560 | +172% |
| Profit (loss) for the period to be appropriated | 9905 | €49,088 | €133,647 | +€84,560 | +172% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.